BIOMARIN PHARMACEUTICAL INC (BMRN) Stock Price, Quote, News and Overview
NASDAQ:BMRN - Nasdaq - US09061G1013 - Common Stock - Currency: USD
BMRN Quote, Performance and Key Statistics
BIOMARIN PHARMACEUTICAL INC
NASDAQ:BMRN (1/24/2025, 8:27:54 PM)
After market: 61.9999 +0.27 (+0.44%)61.73
-0.46 (-0.74%)
The current stock price of BMRN is 61.73 USD. In the past month the price decreased by -6.85%. In the past year, price decreased by -32.07%.
BMRN Latest News, Press Releases and Analysis
NASDAQ:BMRN is showing decent growth, but is still valued reasonably.
Don't overlook NASDAQ:BMRN—a stock with solid growth prospects and a reasonable valuation.
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN.
BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has initiated a legal action against Ascendis Pharma A/S for...
Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators
Alger launched its INVN ETF, with holdings including BioMarin, Teradata, and Bristol-Myers Squibb.
BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will...
10 Magnificent Stocks That Can Make You Richer in 2025
A new year brings with it new opportunities to grow your wealth on Wall Street.
BMRN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.84 | 300.94B | ||
| AMGN | AMGEN INC | 14.33 | 148.05B | ||
| GILD | GILEAD SCIENCES INC | 21.01 | 115.99B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 862 | 113.22B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.88 | 74.26B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.80B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.47B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.64B | ||
| NTRA | NATERA INC | N/A | 22.13B | ||
| BIIB | BIOGEN INC | 8.95 | 21.30B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.52B |
Related stock screener links
About BMRN
Company Profile
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. The company is headquartered in Novato, California and currently employs 3,401 full-time employees. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.
Company Info
BIOMARIN PHARMACEUTICAL INC
105 Digital Drive
Novato CALIFORNIA 94901 US
CEO: Jean-Jacques Bienaime
Employees: 3401
Company Website: https://www.biomarin.com/
Investor Relations: https://investors.biomarin.com/
Phone: 14155056700
BMRN FAQ
What is the stock price of BMRN?
The current stock price of BMRN is 61.73 USD.
What is the symbol for BIOMARIN PHARMACEUTICAL INC stock?
The exchange symbol of BIOMARIN PHARMACEUTICAL INC is BMRN and it is listed on the Nasdaq exchange.
On which exchange is BMRN stock listed?
BMRN stock is listed on the Nasdaq exchange.
Is BMRN a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for BMRN, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of BMRN.
Does BMRN stock pay dividends?
BMRN does not pay a dividend.
When does BMRN stock report earnings?
BMRN will report earnings on 2025-02-20, after the market close.
What is the Price/Earnings (PE) ratio of BMRN?
The PE ratio for BMRN is 35.27. This is based on the reported non-GAAP earnings per share of 1.75 and the current share price of 61.73 USD.
What is the Short Interest ratio of BMRN stock?
The outstanding short interest for BMRN is 2.4% of its float.
BMRN Technical Analysis
BMRN Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to BMRN. BMRN gets an excellent profitability rating and is at the same time showing great financial health properties.
BMRN Financial Highlights
Over the last trailing twelve months BMRN reported a non-GAAP Earnings per Share(EPS) of 1.75. The EPS decreased by 127.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.71% | ||
| ROA | 4.7% | ||
| ROE | 5.95% | ||
| Debt/Equity | 0.11 |
BMRN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 81% to BMRN. The Buy consensus is the average rating of analysts ratings from 35 analysts.
For the next year, analysts expect an EPS growth of 119.97% and a revenue growth 17.05% for BMRN